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The Looming Crisis of Health Care
Jake Harper, First Year JD Candidate
Medicare represents the most critical revenue stream
for doctors and hospitals throughout the United States.
Medicare funding in 2008 was 20% of all federal
spending, or $599 billion. Because the program is so
heavily funded, it has attracted its fair share of abusers
of the system.
The federal government has taken many reactive
steps to address the surge of fraud and abuse in the
Medicare system, reinforced by the Health Insurance
Portability and Accountability Act of 1996 (HIPAA).
HIPAA, while enacted to help protect private health
information, also was designed to combat health
care fraud. HIPAA allocated substantial funds to the
Department of Health and Human Services (HHS)
through the Health Care Fraud and Abuse Program
to implement more effective anti-fraud measures.
Currently, hundreds of millions of dollars are used to
fight Medicare fraud. HHS has created special entities
designed solely to address fraud over the past few
years, including Recovery Audit Contractors, Program
Safeguard Contractors and Zone Program Integrity
Contractors and, as well, strengthened FBI and HHS
fraud investigative units.
Why, then, is there still a crisis looming for our health
care system? Simply put, these anti-fraud programs
have also swept up many well-meaning providers
during their reviews, driving legitimate doctors, clinics
and hospitals out of business. Medicare contractors
utilize data mining, where they review claims data to
identify outliers. With a myriad of ways to review the
data, nearly every provider can become an outlier in
some respect. Once selected for review, a health care
provider then undergoes the extremely difficult audit
process, which may result in massive penalties and
overpayments, or even complete exclusion from the
Medicare program by the HHS Office of Inspector
General. Many doctors fear these audits, and others
are simply choosing to opt out of Medicare, thereby
rejecting Medicare patients altogether. This trend is
not only rising, but accelerating. With the federal
government taking an even greater role in health care
in the coming years, substantial reform in identifying
and prosecuting fraudulent activities is warranted.
Electronic Medical Records: Too much Too
Soon?
Jake Harper, First Year JD Candidate
Electronic medical records (EMR) are the future
of health care and undoubtedly will someday help
improve the quality of care for patients. But before
backing the full implementation of EMR, it is
important to consider some of its shortcomings and
inadequacies.
The most startling concern for both patients and
providers is the potential breach of security and
privacy to which EMR is susceptible. Americans have
long feared the unapproved use of their personal health
information, a sentiment embodied in the HIPAA.
Additionally, the widespread use of the Internet in
recent years has led to a sharp increase in identity
theft, particularly of medical information. With
EMR emerging as the preferred choice for medical
documentation, those involved must first be sure
that the system is adequately secure. This becomes
especially problematic when attempting to integrate the
security and compatibility of numerous independently-
developed software platforms. While the HHS Office
of the National Coordinator for Health Information
Technology is expected to remedy this problem,
EMR is currently easy for unauthorized individuals
to access. Moreover, EMR multiplies the number of
people with access to a patient's records (providers,
clinics, hospitals, billers, insurers and auditors) from
about 120 interventions with paper records to over
600,000 through EMR. Until these privacy problems
are addressed, patients and doctors alike should remain
cautious about the use of EMR.
Aside from the privacy issue, the cost-benefit of EMR
has not been affirmatively established, especially
for individual doctors and clinics. While billions of
dollars in savings have been projected through the
implementation of EMR, the costs of purchasing,
training and beginning "meaningful use" of EMR are
generally too high for individual providers. Though
the government has incentivized the program to some
extent through the HITECH Act, part of the ARRA
(the stimulus law), the current rewards and penalties
are insufficient for doctors to justify the cost, even
from a purely economic standpoint. Until standard
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programs and procedures for EMR are established,
with little to no upfront cost to those mandated to use
it, it is unlikely that the implementation of EMR will
be as successful as proponents have forecasted.
The Children's Health Insurance Battle
Krista Maier, Third Year JD Candidate
The battle over children's health insurance coverage
is in full swing. It began in September, when major
health insurers, including WellPoint, CIGNA and
CoventryOne, announced that they will no longer
offer child-only plans. This announcement came
days before the start of the Patient Protection and
Affordable Care Act's (PPACA) prohibition against
denying health coverage for people with pre-existing
medical conditions. The insurance companies stated
that uncertainty in the market and fear that parents
will wait until their children get sick before buying
health insurance led to the decision to drop these plans.
Advocacy groups and the HHS believed, however, that
the move was a way to avoid providing new policies
for sick children.
In October, HHS Secretary Kathleen Sebelius struck
back. In a letter to the National Association of
Insurance Commissioners (NAIC), Sebelius criticized
the arguments that the insurance companies are
relying on to deny coverage to children, stating that
they are "legally infirm" and inconsistent with the
language of PPACA. Sebelius outlined other ways
to counter potential adverse selection: the premise
that, if only sick people buy health insurance, an
insurance company's costs will increase greatly. Most
of Sebelius' suggestions are temporary fixes until the
state health insurance exchanges are up and running
in 2014-including the suggestion that insurers may
adjust rates for children's plans based on health status,
a policy which will be prohibited by PPACA for new
plans starting in 2014. Sebelius also urged states to
continue to regulate "discrimination against children"
with pre-existing conditions.
So now, the proverbial ball is back in the insurance
industry's court. Time will tell whether they accept
Sebelius's suggestions, or develop their own solution
to the children's health insurance issue.
Controlled Substance Prescriptions Now
Allowed in Take-Back Programs
Krista Maier, Third Year JD Candidate
According to a 2009 Department of Justice report,
crimes associated with controlled prescription drugs
have increased nationwide over the past five years.
In addition, the Office of National Drug Control
Policy reported that, in 2008, one-third of all new
prescription drug abusers were between ages 12 and
17. In an effort to limit access to prescription drugs,
many states have implemented their own drug disposal
programs, also called "take-back" programs. Through
these programs, the state collects and destroys unused
or expired medications, limiting teens' access to these
medications in their homes.
Even with such programs in place, abuse of controlled
prescription drugs continues to increase in the U.S. This
is due in part because these programs generally do not
accept controlled substances, such as amphetamine,
morphine and codeine, as federal law requires special
permission from the Drug Enforcement Administration
and full-time police officers to receive the medication.
To address this, President Obama signed into law
the Secure and Responsible Drug Disposal Act of
2010 (S.3397). This law modifies existing controlled
substances law, allowing people who have legally
obtained a controlled prescription drug to bring
that drug to a disposal program without advance
permission. The law requires the Attorney General to
provide regulations for controlled substance take-back
programs, considering both public health and safety,
and also the costs of implementing such programs.
In addition, the law allows long-term care facilities
to dispose of their residents' controlled substances on
their behalf, subject to guidelines from the Attorney
General. Finally, the law also allows people who are
authorized to dispose of a decedent's property to bring
the decedent's controlled prescription drugs to a take-
back program.
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Privacy in Hospital Rooms
Kirsten Tullia, Second Year JD Candidate
With the first FDA license to use cell-based treatment
in hand, Geron, a pharmaceutical and biologics
manufacturer, began treatment on the first patient to
receive human embryonic stem cells on October 11,
2010. Although Geron has not released many details
concerning the procedure, the basic premise is that
patients with spinal cord injuries will be injected with
oligodendrocyte precursor cells, grown from human
embryonic stem cells, in the hope that these new cells
will regenerate damaged tissue. In this early phase of
stem cell treatment, the aim is to determine the safety
of the procedure rather than its efficacy.
This procedure is not without its risks, however.
Embryonic stem cells are undifferentiated "master
cells," leaving them capable of becoming any of the
hundred of cell types in the human body -including
cancer cells. Early tests using embryonic stem cells
to treat Parkinson's disease met a grisly end when the
cells reproduced at an uncontrolled rate and actually
worsened the patients' muscle control problems.
In order to lower the risk of unmitigated growth,
Geron's researchers first ensured that the cells were
differentiated into normal tissue before giving them to
patients.
There are also important policy implications in
embryonic stem cell implantation. Critics of embryonic
stem cell research believe it is wrong to use an embryo
to obtain the cells. President George W Bush placed
strict limitations on their use during his presidency.
President Barack Obama loosened these limitations
just weeks after he took office, allowing researchers
to use embryonic stem cells from human embryos left
over from fertility treatments.
Despite the controversial nature of the treatment,
embryonic stem cell treatment is a huge step forward
for those who suffer from degenerative diseases such
as Parkinson's and muscular dystrophy. As Professor
Pete Coffey of University College London said, "There
are still many years of rigorous testing ahead and there
will be setbacks and failures before we have safe and
effective cell-based therapies. But this first in man
study marks the dawn of the 'Stem Cell Age'."
Kirsten Tullia, Second Year JD Candidate
In response to a growing patient demand for private
rooms, a number of local Washington, DC, area
hospitals have already converted or are in the process
of converting their facilities to all private rooms. One
notable entity pushing for private patient rooms is
Inova Fairfax Hospital, the largest hospital in Northern
Virginia and the only Level 1 trauma unit in the
Northern Virginia area. Inova Fairfax's expansion calls
for a new general hospital tower comprised of private
rooms and a new women's hospital. These renovations
will cost approximately $161 million dollars, which
Inova Fairfax plans to fund through debt and some use
of cash reserves. Interestingly, however, this building
expansion will not drastically increase the capacity
of these already large hospitals. Inova Fairfax's
construction plan, for example, will cost approximately
$161 million dollars but only will produce about 174
new private rooms.
Hospital officials presented many different reasons
for these changes, including fewer cases of infection
and more space for medical equipment. Roger Urlich
from Texas A&M University has a different opinion:
"The attitude of viewing patients as objects has shifted.
Hospitals are now in the consumer service business."
With the passage of the Patient Protection and
Affordable Care Act last winter and its first provisions
coming to life just a few months ago, the American
public is quickly becoming more versed in health
issues, and is demanding more from its providers as
a direct result of this knowledge. While the push for
private rooms predates the Affordable Care Act, we
can expect to see more action on the part of health
care providers as they rise to the challenge of the new
American health care consumer.
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A Provision of Health Care Reform:
Positive or Negative For People with
Di1.s a bli 't ie s?
Gary C. Norman, Esq., LLM Candidate
The Patient Protection and Affordable Care Act of 2010
(PPACA) spurs the federal government into action by
requiring a rulemaking on health care service delivery
for people with disabilities by The Architectural and
Transportation Barriers Compliance Board (commonly
known as The U.S. Access Board). Section 4203 of the
PPACA requires the promulgation of a new subsection
of the Rehabilitation Act of 1973 to address the barrier
of inaccessible diagnostic medical equipment.
The Board must promulgate standards on medical
diagnostic equipment within twenty-four months
after enactment, in consultation with the Food and
Drug Administration and in accordance with the
Administrative Procedures Act. Under the new
standards, to the maximum extent possible, people with
disabilities should be able to independently utilize-
transfer to and from, enter and exit from-an array
of examination chairs and tables in medical settings
such as hospital emergency rooms. Mammography
equipment is an example of the type of equipment
specifically mentioned in the provision. Women with
disabilities, especially mobility impairments, have also
historically been victims of inaccessible gynecological
exam equipment.
The requirements under section 4203 of the PPACA
help to reveal a gap in current health care service
delivery to more than fifty-four million citizens. Once
these standards are enacted it will not a priori mean
that providers will comply. Currently, the PPACA
contains insufficient enforcement authority. Lacking is
a clear indication of who has enforcement authority;
as well, the PPACA does not provide sufficient
appropriations for training on the standards. Since the
PPACA designates the U.S. Access Board to formulate
accessibility standards, many presume that the
Board will also have enforcement authority on such
standards. However, the Board is not an agency, and is
best described as an advisory body or an information
clearinghouse on accessibility issues. If the Board does
not become the enforcement authority the next logical
choice is the Office of Civil Rights at the United States
Department of Health and Human Services.
Only time will tell if these standards constitute a
valuable mechanism for improving the quality of
health care for people with disabilities.
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